GS-441524 30mg/ml 6ml Injection for Feline FIP Veterinary Treatment

GS-441524 Injectable Solution

GS-441524 is an antiviral nucleoside analogue that has been widely discussed in veterinary treatment programs for feline infectious peritonitis (FIP). The injectable form provides a liquid preparation that can be administered according to a cat’s body weight and clinical condition.

This formulation contains 30mg/ml GS-441524 and is supplied in a 6ml vial. The higher concentration provides a smaller administration volume than lower-strength formulations when the same amount of active ingredient is required. This can be useful when a veterinarian is developing a daily treatment plan for a cat undergoing FIP management.

FIP can affect cats in different ways. Some cases are associated with fluid accumulation, while others mainly involve internal organs, the eyes, or the nervous system. For this reason, the amount administered is generally considered together with the individual cat’s weight, clinical presentation, and response to treatment rather than using one fixed amount for every case.

The 6ml injectable format is suitable for veterinary clinics, feline care providers, rescue organizations, and supervised treatment programs where a concentrated GS-441524 formulation is required.

Product Details

Why GS-441524 Is Used in FIP Treatment

Feline infectious peritonitis develops when feline coronavirus undergoes mutation and becomes capable of causing a systemic disease. Once this occurs, the infection may involve different tissues and organs, resulting in a wide range of clinical signs.

GS-441524 is used in antiviral treatment approaches because it interferes with the viral replication process. The purpose of antiviral treatment is to reduce viral activity while the cat’s immune system recovers and the clinical signs are monitored.

The response to treatment can vary between cats. Body weight, disease stage, organ involvement, and general health are all relevant when a veterinarian evaluates an FIP treatment plan.

Different Forms of FIP

Effusive or Wet FIP

Wet FIP is commonly associated with fluid accumulation in the abdomen or chest. Affected cats may show abdominal enlargement, reduced appetite, tiredness, or breathing changes depending on the amount and location of fluid.

Non-Effusive or Dry FIP

Dry FIP can involve inflammatory lesions in internal organs without the obvious fluid accumulation seen in effusive cases. The symptoms depend largely on which organs are affected.

Ocular FIP

When FIP involves the eyes, inflammation may result in changes to eye appearance or vision. Ocular involvement can require particular attention during veterinary monitoring.

Neurological FIP

Neurological FIP occurs when the central nervous system is involved. Possible signs include balance problems, unusual movement, weakness, tremors, or changes in normal behavior.

Because these forms can present differently, the treatment approach should be assessed on an individual basis.

Reference Administration Information

These values are reference information rather than a universal prescription for every cat. A veterinarian should determine the appropriate treatment plan based on the animal’s current weight, clinical presentation, treatment response, and other relevant findings.

What Makes the 30mg/ml Formulation Different?

Higher Concentration

At 30mg/ml, this formulation contains more active ingredient in each milliliter than a 20mg/ml preparation. As a result, the required administration volume can be lower when an equivalent amount of GS-441524 is needed.

6ml Vial Format

The 6ml vial provides a practical size for treatment programs where a smaller package is preferred. It is also convenient for storage, inventory management, and routine veterinary supply.

Liquid Dosage Form

A liquid formulation allows the administration volume to be calculated according to body weight. This provides flexibility when the cat’s weight changes during treatment.

Suitable for Veterinary Treatment Programs

The formulation can be incorporated into FIP management programs involving wet, dry, ocular, neurological, or recurrent disease presentations, with the treatment approach adjusted according to the individual case.

Where the Product May Be Used

Veterinary Practices

Veterinary clinics may use GS-441524 injection as part of a monitored FIP treatment program. During treatment, body weight and general condition can be reviewed regularly so that the treatment plan can be adjusted when necessary.

Feline Rescue Organizations

Rescue groups caring for cats with FIP may require injectable antiviral products for animals receiving veterinary-supervised treatment.

Multi-Cat Facilities

Breeding facilities and other environments housing multiple cats may encounter FIP cases that require professional diagnosis and treatment planning. Injectable formulations can be supplied as part of an appropriate veterinary care program.

Home Treatment Under Veterinary Guidance

After an initial veterinary assessment, some cats may continue their treatment outside the clinic. In these situations, administration should follow the instructions provided by the attending veterinarian.

Handling and Storage

The product should be kept at room temperature in a clean, dry place. Avoid prolonged exposure to direct sunlight, excessive heat, or moisture.

Keep the vial properly closed when not in use. Injectable products should be handled using appropriate sterile practices. Before administration, check the vial and packaging for visible damage or unusual changes.

The stated shelf life is one year from the manufacturing date when stored under the recommended conditions.

Manufacturing and Product Traceability

GS-441524 injection is manufactured in China under controlled production procedures. Product labeling and batch information can be used to support traceability during distribution and inventory management.

The 30mg/ml 6ml presentation provides a concentrated injectable option within the GS-441524 product range, giving veterinary suppliers and feline care providers another format for FIP treatment programs.

Important Notice

This product is intended for veterinary use. FIP treatment should be managed by a qualified veterinary professional. Dosage, administration frequency, and treatment duration should be determined according to the cat’s body weight, disease presentation, clinical response, and overall health condition.